349
Participants
Start Date
September 30, 2005
Primary Completion Date
March 31, 2009
Study Completion Date
March 31, 2009
Sulfadoxine-pyrimethamine (SP) + Artesunate (AS)
Monthly chemoprophylaxis with SP (Fansidar® 500/25 mg) plus Artesunate (AS, Arsumax® 50 mg) or placebo (provided by Roche and Sanofi-Aventis) was administered according to the following age-based dosing schedule: ½ tablet of SP or placebo and ½ tablet of AS or placebo on the first day and ½ tablet of AS or placebo on the second and third days.
Centro de Investigaçao em Saude da Manhiça, Manhiça
European Commission
OTHER
Hospital Clinic of Barcelona
OTHER